BORCS7
gene geneOn this page
Also known as FLJ40752
Summary
BORCS7 (BLOC-1 related complex subunit 7, HGNC:23516) is a protein-coding gene on chromosome 10q24.32, encoding BLOC-1-related complex subunit 7 (Q96B45). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery.
Predicted to be involved in organelle transport along microtubule; regulation of endosome size; and regulation of lysosome size. Predicted to act upstream of or within several processes, including lysosome localization; motor behavior; and response to cycloheximide. Part of BORC complex.
Source: NCBI Gene 119032 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 25 (top 5% of genes corpus-wide)
- Clinical variants (ClinVar): 17 total
- GTEx eGene: eQTL in 49 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.48 (unconstrained)
- MANE Select transcript:
NM_001136200
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23516 |
| Approved symbol | BORCS7 |
| Name | BLOC-1 related complex subunit 7 |
| Location | 10q24.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40752 |
| Ensembl gene | ENSG00000166275 |
| Ensembl biotype | protein_coding |
| OMIM | 616600 |
| Entrez | 119032 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
MANE Select: ENST00000339834
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 2: 1
ENST00000339834, ENST00000369883, ENST00000478833, ENST00000878900, ENST00000997733, ENST00001019959, ENST00001119440, ENST00001128035, ENST00001139263
RefSeq mRNA: 2 — MANE Select: NM_001136200
NM_001136200, NM_144591
CCDS: CCDS7542
Canonical transcript exons
ENST00000339834 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001432461 | 102862873 | 102864961 |
| ENSE00001846473 | 102854259 | 102854427 |
| ENSE00003481243 | 102860332 | 102860394 |
| ENSE00003549423 | 102860498 | 102860541 |
| ENSE00003566433 | 102862160 | 102862180 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 96.56.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0880 / max 22.1598, expressed in 800 samples.
Highest expression (Bgee): adrenal tissue, ventricle myocardium, kidney epithelium, palpebral conjunctiva, cardiac muscle of right atrium.
Genetic regulation across tissues (GTEx eQTL / sQTL)
BORCS7 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 49 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 49 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Adipose Subcutaneous | eqtl | 8.1e-91 | -0.69 | 10:102863296:C:G |
| Nerve Tibial | eqtl | 1.1e-84 | -0.59 | 10:102863296:C:G |
| Esophagus Mucosa | eqtl | 2.7e-84 | -0.84 | 10:102863296:C:G |
| Artery Tibial | eqtl | 2.6e-83 | -0.60 | 10:102863296:C:G |
| Thyroid | eqtl | 1.0e-75 | -0.46 | 10:102863821:C:T |
| Adipose Visceral Omentum | eqtl | 1.1e-71 | -0.71 | 10:102863821:C:T |
| Skin Sun Exposed Lower leg | eqtl | 1.5e-66 | -0.43 | 10:102863296:C:G |
| Artery Aorta | eqtl | 2.3e-58 | -0.67 | 10:102856743:T:C |
| Cells Cultured fibroblasts | eqtl | 4.7e-58 | -0.36 | 10:102863296:C:G |
| Lung | eqtl | 5.1e-58 | -0.62 | 10:102863821:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 1.1e-56 | -0.43 | 10:102863821:C:T |
| Esophagus Muscularis | eqtl | 2.8e-54 | -0.57 | 10:102863821:C:T |
| Breast Mammary Tissue | eqtl | 5.8e-53 | -0.54 | 10:102863296:C:G |
| Heart Atrial Appendage | eqtl | 2.5e-52 | -0.61 | 10:102863296:C:G |
| Colon Transverse | eqtl | 2.5e-52 | -0.58 | 10:102856743:T:C |
| Colon Sigmoid | eqtl | 2.5e-39 | -0.54 | 10:102863821:C:T |
| Brain Caudate basal ganglia | eqtl | 2.7e-38 | -0.64 | 10:102856743:T:C |
| Esophagus Gastroesophageal Junction | eqtl | 5.6e-37 | -0.60 | 10:102863821:C:T |
| Brain Frontal Cortex BA9 | eqtl | 8.1e-37 | -0.71 | 10:102856743:T:C |
| Heart Left Ventricle | eqtl | 8.8e-37 | -0.50 | 10:102863821:C:T |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106774 | 21.0684 | 1802 |
| 106773 | 1.0880 | 800 |
Top tissues by expression
showing 100 of 256 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 96.56 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.48 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.26 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 96.19 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.77 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.65 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 95.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.59 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.56 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.52 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.43 | gold quality |
| adrenal cortex | UBERON:0001235 | 95.34 | gold quality |
| parietal pleura | UBERON:0002400 | 95.25 | gold quality |
| bronchus | UBERON:0002185 | 95.02 | gold quality |
| adrenal gland | UBERON:0002369 | 94.98 | gold quality |
| endothelial cell | CL:0000115 | 94.72 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.23 | gold quality |
| deltoid | UBERON:0001476 | 94.16 | gold quality |
| tibia | UBERON:0000979 | 93.83 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.72 | gold quality |
| skin of hip | UBERON:0001554 | 93.11 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 93.11 | gold quality |
| visceral pleura | UBERON:0002401 | 93.10 | gold quality |
| upper arm skin | UBERON:0004263 | 93.05 | gold quality |
| quadriceps femoris | UBERON:0001377 | 92.99 | gold quality |
| myocardium | UBERON:0002349 | 92.88 | gold quality |
| vastus lateralis | UBERON:0001379 | 92.73 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 92.72 | gold quality |
| superficial temporal artery | UBERON:0001614 | 92.43 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.29 | gold quality |
| liver | UBERON:0002107 | 92.19 | gold quality |
| caput epididymis | UBERON:0004358 | 92.16 | gold quality |
| thyroid gland | UBERON:0002046 | 92.07 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.97 | gold quality |
| seminal vesicle | UBERON:0000998 | 91.77 | gold quality |
| upper leg skin | UBERON:0004262 | 91.66 | gold quality |
| metanephros | UBERON:0000081 | 91.64 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.63 | gold quality |
| nucleus accumbens | UBERON:0001882 | 91.61 | gold quality |
| monocyte | CL:0000576 | 91.56 | gold quality |
| decidua | UBERON:0002450 | 91.53 | gold quality |
| adult organism | UBERON:0007023 | 91.52 | gold quality |
| corpus epididymis | UBERON:0004359 | 91.39 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.30 | gold quality |
| leukocyte | CL:0000738 | 91.22 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 91.18 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 91.17 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 91.12 | gold quality |
| placenta | UBERON:0001987 | 91.07 | gold quality |
| kidney | UBERON:0002113 | 90.87 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 90.87 | gold quality |
| cartilage tissue | UBERON:0002418 | 90.82 | gold quality |
| muscle tissue | UBERON:0002385 | 90.80 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 90.78 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.77 | gold quality |
| biceps brachii | UBERON:0001507 | 90.75 | gold quality |
| mammary gland | UBERON:0001911 | 90.75 | gold quality |
| jejunal mucosa | UBERON:0000399 | 90.66 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.56 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.56 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.47 | gold quality |
| amygdala | UBERON:0001876 | 90.44 | gold quality |
| jejunum | UBERON:0002115 | 90.41 | gold quality |
| hypothalamus | UBERON:0001898 | 90.37 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 90.34 | gold quality |
| endometrium | UBERON:0001295 | 90.33 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 90.25 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.22 | gold quality |
| gall bladder | UBERON:0002110 | 90.18 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 90.10 | gold quality |
| adipose tissue | UBERON:0001013 | 90.03 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.02 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.02 | gold quality |
| duodenum | UBERON:0002114 | 90.00 | gold quality |
| Ammon’s horn | UBERON:0001954 | 89.96 | gold quality |
| spinal cord | UBERON:0002240 | 89.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 89.95 | gold quality |
| pituitary gland | UBERON:0000007 | 89.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.78 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 89.76 | gold quality |
| endocervix | UBERON:0000458 | 89.75 | gold quality |
| forebrain | UBERON:0001890 | 89.71 | gold quality |
| fallopian tube | UBERON:0003889 | 89.66 | gold quality |
| muscle of leg | UBERON:0001383 | 89.60 | gold quality |
| temporal lobe | UBERON:0001871 | 89.56 | gold quality |
| cerebral cortex | UBERON:0000956 | 89.54 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 89.54 | gold quality |
| postcentral gyrus | UBERON:0002581 | 89.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.50 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.49 | gold quality |
| ventricular zone | UBERON:0003053 | 89.39 | gold quality |
| islet of Langerhans | UBERON:0000006 | 89.36 | gold quality |
| neocortex | UBERON:0001950 | 89.36 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.36 | gold quality |
| putamen | UBERON:0001874 | 89.31 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 89.31 | gold quality |
| frontal cortex | UBERON:0001870 | 89.30 | gold quality |
| substantia nigra | UBERON:0002038 | 89.30 | gold quality |
| right uterine tube | UBERON:0001302 | 89.28 | gold quality |
| mammary duct | UBERON:0001765 | 89.27 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-88 | yes | 19.36 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Liver | tissue | 62.7 | medium |
| Adrenal gland | tissue | 54.4 | high |
| Thyroid gland | tissue | 51.8 | high |
| Parathyroid gland | tissue | 50.1 | medium |
| Putamen | tissue | 39.9 | |
| Kidney | tissue | 37.1 | medium |
| Cerebral cortex | tissue | 36.9 | medium |
| Somatosensory cortex | tissue | 36.9 | |
| Motor cortex | tissue | 35.8 | |
| Hippocampal formation | tissue | 35.8 | |
| Entorhinal cortex | tissue | 35.8 | |
| Occipital cortex | tissue | 35.2 | |
| Ventral forebrain | tissue | 34.9 | |
| Retrosplenial and cingulate cortex | tissue | 34.5 | |
| Amygdala | tissue | 33.8 | |
| Retrosplenial cortex | tissue | 33.8 | |
| Septum | tissue | 33.3 | |
| Olfactory bulb | tissue | 33.2 | |
| Prefrontal cortex | tissue | 33.1 | |
| Basal ganglia | tissue | 33.1 | medium |
| Temporal cortex | tissue | 32.8 | |
| Insular cortex | tissue | 32.7 | |
| Midbrain | tissue | 32.5 | |
| Spinal cord | tissue | 32.3 | |
| Thalamus | tissue | 32.2 | |
| Corpus callosum | tissue | 31.5 | |
| Pons | tissue | 30.1 | |
| Substantia nigra | tissue | 29.9 | |
| Hypothalamus | tissue | 29.6 | |
| Medulla oblongata | tissue | 29.4 | |
| Superior colliculi | tissue | 28.1 | |
| Breast | tissue | 27.9 | high |
| Fallopian tube | tissue | 27.9 | high |
| Periaqueductal gray | tissue | 27.4 | |
| Cerebellum | tissue | 27.2 | medium |
| Ovary | tissue | 25.7 | low |
| Prostate | tissue | 25.5 | medium |
| Skeletal muscle | tissue | 24.8 | low |
| Tongue | tissue | 24.1 | |
| Adipose tissue | tissue | 23.8 | high |
| Spleen | tissue | 23.0 | medium |
| Epididymis | tissue | 22.4 | high |
| Lung | tissue | 22.4 | high |
| Pituitary gland | tissue | 22.1 | |
| Bone marrow | tissue | 22.0 | low |
| Duodenum | tissue | 21.8 | medium |
| Gallbladder | tissue | 21.0 | medium |
| Heart muscle | tissue | 20.7 | medium |
| Endometrium 1 | tissue | 20.4 | medium |
| Placenta | tissue | 20.4 | medium |
| Cervix | tissue | 19.7 | medium |
| Stomach 1 | tissue | 19.7 | medium |
| Testis | tissue | 18.9 | medium |
| Retina | tissue | 18.7 | |
| Choroid plexus | tissue | 18.5 | |
| Small intestine | tissue | 18.3 | high |
| Frontal cortex | tissue | 18.2 | |
| Pancreas | tissue | 16.5 | medium |
| Seminal vesicle | tissue | 16.4 | medium |
| Colon | tissue | 16.1 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Dorsal hippocampus (35.6), Subiculum (34.2), Ventral hippocampus (34.1), Ventral spinal cord (32.3), White matter (31.5).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting BORCS7 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 63 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-4782-3P | 99.88 | 73.31 | 735 |
| HSA-MIR-6766-3P | 99.88 | 73.38 | 732 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
Functional genomics
gnomAD constraint: pLI 0.000525, LOEUF 1.48, missense Z -0.126 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000339834 — one region, missense o/e 0.94.
Literature-anchored findings (GeneRIF, showing 5)
- this study implicates altered neural expression of BORCS7, AS3MT, and NT5C2 in susceptibility to schizophrenia arising from genetic variation at the chromosome 10q24 locus (PMID:27004590)
- Risk alleles spanning multiple genes across the 10q24.32 schizophrenia-related locus are associated in the human brain selectively with an increase in the expression of both BLOC-1 related complex subunit 7 (BORCS7) and a previously uncharacterized, human-specific arsenite methyltransferase (AS3MT) isoform (AS3MTd2d3). (PMID:27158905)
- Sngle nucleotide polymorphism in c10orf32 gene is associated with skin lesions. (PMID:27692299)
- effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: a PET imaging study (PMID:31386983)
- BORC complex specific components and Kinesin-1 mediate autophagy evasion by the autophagy-resistant Mycobacterium tuberculosis Beijing strain. (PMID:36717601)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | borcs7 | ENSDARG00000055070 |
| mus_musculus | Borcs7 | ENSMUSG00000062376 |
| rattus_norvegicus | Borcs7 | ENSRNOG00000073762 |
| drosophila_melanogaster | BORCS7 | FBGN0034519 |
| caenorhabditis_elegans | WBGENE00010981 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913689) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 19 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| tremors | 1 |
| abnormal retina morphology | 1 |
| ataxia | 1 |
| hyperactivity | 1 |
| impaired coordination | 1 |
| abnormal gait | 1 |
| abnormal spatial learning | 1 |
| decreased startle reflex | 1 |
| limb grasping | 1 |
| reduced male fertility | 1 |
| decreased vertical activity | 1 |
| abnormal retina vasculature morphology | 1 |
| axonal dystrophy | 1 |
| abnormal axonal transport | 1 |
| abnormal lysosome morphology | 1 |
| decreased grip strength | 1 |
| abnormal retina blood vessel morphology | 1 |
| neonatal lethality, complete penetrance | 1 |
| preweaning lethality, complete penetrance | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pongo abelii | Q5REK7 | 98.1% | Diamond |
| Bos taurus | Q2KIB7 | 97.1% | Diamond |
| Xenopus tropicalis | Q28DH3 | 88.3% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| BORCS7-ASMT | ncRNA | 100528007 |
| NT5C2 | protein-coding | 22978 |
| CNNM2 | protein-coding | 54805 |
| AS3MT | protein-coding | 57412 |
| CYP17A1-AS1 | ncRNA | 102724307 |
| CYP17A1 | protein-coding | 1586 |
| WBP1L | protein-coding | 54838 |
Protein
Protein identifiers
BLOC-1-related complex subunit 7 — Q96B45 (reviewed: Q96B45)
Alternative names: Diaskedin
All UniProt accessions (1): Q96B45
UniProt curated annotations — full annotation on UniProt →
Function. As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor.
Subunit / interactions. Component of the BLOC-one-related complex (BORC) which is composed of BLOC1S1, BLOC1S2, BORCS5, BORCS6, BORCS7, BORCS8, KXD1 and SNAPIN.
Subcellular location. Lysosome membrane.
Miscellaneous. Diaskedin is from the ancient Greek diaskedazo, meaning to disperse.
Similarity. Belongs to the BORCS7 family.
RefSeq proteins (2): NP_001129672, NP_653192 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032143 | BORCS7 | Family |
Pfam: PF16088
UniProt features (1 total): chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96B45-F1 | 94.84 | 0.90 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, UniProt - Inferred from homology
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; vesicles
Antibody reliability (HPA): IH approved · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 146 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_BEHAVIOR, GOCC_VACUOLAR_MEMBRANE, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_NEUROGENESIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_RESPONSE_TO_KETONE, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_CELL_PROJECTION_ORGANIZATION
GO Biological Process (4): lysosome localization (GO:0032418), regulation of endosome size (GO:0051036), regulation of lysosome size (GO:0062196), organelle transport along microtubule (GO:0072384)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): cytoplasmic side of lysosomal membrane (GO:0098574), BORC complex (GO:0099078), lysosome (GO:0005764), lysosomal membrane (GO:0005765)
GO top-level categories
12 GO namespaces:
| Category | Terms |
|---|---|
| vacuolar localization | 1 |
| regulation of vesicle size | 1 |
| regulation of cellular component size | 1 |
| transport along microtubule | 1 |
| establishment of organelle localization | 1 |
| binding | 1 |
| lysosomal membrane | 1 |
| cytoplasmic side of membrane | 1 |
| intracellular protein-containing complex | 1 |
| lytic vacuole | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 9 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| BORC complex | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 494 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BORCS7 | BORCS5 | Q969J3 | 772 |
| BORCS7 | BORCS6 | Q96GS4 | 759 |
| BORCS7 | BORCS8 | Q96FH0 | 757 |
| BORCS7 | KXD1 | Q9BQD3 | 756 |
| BORCS7 | AS3MT | Q9HBK9 | 722 |
| BORCS7 | SNAPIN | O95295 | 678 |
| BORCS7 | BLOC1S1 | P78537 | 678 |
| BORCS7 | BLOC1S2 | Q6QNY1 | 675 |
| BORCS7 | NT5C2 | P49902 | 611 |
| BORCS7 | ARL8B | Q9NVJ2 | 601 |
| BORCS7 | ARL5B | Q96KC2 | 592 |
| BORCS7 | CNNM2 | Q9H8M5 | 591 |
| BORCS7 | ARL8A | Q96BM9 | 573 |
| BORCS7 | SLC68A1 | Q14CX5 | 571 |
| BORCS7 | WBP1L | Q9NX94 | 518 |
IntAct
Human interaction partners of BORCS7 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
2 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| WLS | physical association | 0.490 | 2 |
| SNAPIN | association | 0.350 | 2 |
Protein complexes (CORUM) (1)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
1 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| BORC complex | 8 | BORCS5, BORCS6, BORCS7, BORCS8, KXD1, SNAPIN, BLOC1S1, BLOC1S2 |
Disease & clinical
Genetic variants
Variant evidence for BORCS7: 17 ClinVar records (0 pathogenic / likely pathogenic); 25 GWAS associations.
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 35 predictions of 335):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 10:102854428–102854429 | donor_loss | 1.0000 | 5 |
| 10:102854466 | donor_gain | 1.0000 | |
| 10:102860330–102860331 | acceptor_loss | 1.0000 | 6 |
| 10:102860395–102860396 | donor_loss | 1.0000 | 4 |
| 10:102860322 | acceptor_gain | 0.9900 | |
| 10:102860493 | acceptor_gain | 0.9900 | |
| 10:102860496–102860497 | acceptor_loss | 0.9900 | 6 |
| 10:102862152 | acceptor_gain | 0.9900 | |
| 10:102860542–102860543 | donor_loss | 0.9800 | 5 |
| 10:102862158–102862159 | acceptor_loss | 0.9800 | 5 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
4 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 3.18e-10 |
| Kidney Renal Clear Cell Carcinoma (validation) | favorable | 5.21e-05 |
| Liver Hepatocellular Carcinoma (TCGA) | favorable | 0.000158 |
| Ovary Serous Cystadenocarcinoma (validation) | unfavorable | 0.000724 |
Disease associations
OMIM: gene MIM:616600 | disease phenotypes:
GWAS associations
25 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST004946_51 | Schizophrenia | 4e-20 |
| GCST002539_77 | Schizophrenia | 6e-19 |
| GCST006803_98 | Schizophrenia | 7e-18 |
| GCST004946_67 | Schizophrenia | 4e-17 |
| GCST004521_217 | Autism spectrum disorder or schizophrenia | 1e-16 |
| GCST009600_119 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 3e-16 |
| GCST90002403_415 | Red blood cell count | 5e-16 |
| GCST004521_123 | Autism spectrum disorder or schizophrenia | 4e-14 |
| GCST007603_17 | Smoking initiation | 2e-13 |
| GCST002149_2 | Schizophrenia | 4e-13 |
| GCST010703_273 | Brain morphology (MOSTest) | 5e-13 |
| GCST004259_3 | Mean arterial pressure (long-term average) | 1e-11 |
| GCST006231_9 | Mean arterial pressure | 2e-11 |
| GCST007705_21 | Pulse pressure | 2e-11 |
| GCST004904_215 | Body mass index | 5e-11 |
| GCST007707_25 | Hypertension | 4e-10 |
| GCST001942_1 | Prostate cancer | 5e-10 |
| GCST009703_5 | Arsenic metabolism | 2e-9 |
| GCST001421_1 | Arsenic metabolism | 3e-9 |
| GCST004258_2 | Diastolic blood pressure (long-term average) | 8e-9 |
| GCST000528_8 | Parkinson’s disease | 7e-8 |
| GCST005958_7 | Waist-to-hip ratio adjusted for BMI (age >50) | 4e-6 |
| GCST012354_11 | Anxiety | 4e-6 |
| GCST003253_11 | Microalbuminuria | 6e-6 |
| GCST005956_7 | Waist-to-hip ratio adjusted for BMI | 8e-6 |
EFO canonical traits (from GWAS)
10 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004880 | urinary arsenic measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006340 | mean arterial pressure |
| EFO:0004340 | body mass index |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0005670 | smoking initiation |
| EFO:0005763 | pulse pressure measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0009863 | anxiety measurement |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, decreases metabolic processing | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Demecolcine | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Vincristine | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SF96 | HAP1 C10orf32 (-) 1 | Cancer cell line | Male |
| CVCL_SF97 | HAP1 C10orf32 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.